87.77
price up icon0.56%   0.47
 
loading

Incyte Corp Aktie (INCY) Neueste Nachrichten

pulisher
07:46 AM

Does Incyte Corporation show high probability of reboundPortfolio Profit Report & Fast Moving Stock Watchlists - newser.com

07:46 AM
pulisher
Oct 21, 2025

Incyte: Strong Growth, Margin Expansion, And Low Valuation - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

Will Incyte Corporation (ICY) stock enhance shareholder valueTrade Signal Summary & Intraday High Probability Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Incyte Claims Sun Pharma's Alopecia Drug Launch Violates IP - Law360

Oct 21, 2025
pulisher
Oct 21, 2025

Can a trend reversal in Incyte Corporation lead to recoveryEarnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Incyte Corporation (ICY) stock among top earnings playsWeekly Volume Report & High Conviction Buy Zone Picks - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Incyte Corp. Stock Underperforms Monday When Compared To Competitors - 富途牛牛

Oct 21, 2025
pulisher
Oct 21, 2025

Incyte (INCY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Incyte's Quarterly Earnings Preview: What You Need to Know - inkl

Oct 21, 2025
pulisher
Oct 21, 2025

Real time alert setup for Incyte Corporation performance2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Incyte Corporation (ICY) stock undervalued by metricsWeekly Trend Summary & Safe Capital Investment Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Incyte Corporation (ICY) stock dividend growth reliable2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

What’s next for Incyte Corporation stock priceMarket Sentiment Report & Real-Time Buy Signal Notifications - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Can Incyte Corporation (ICY) stock attract analyst upgradesQuarterly Earnings Summary & Weekly Watchlist for Hot Stocks - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Assessing Incyte’s Share Price After Recent FDA Approval and Strong 2024 Gains - Yahoo Finance

Oct 20, 2025
pulisher
Oct 20, 2025

Are You Looking for a Top Momentum Pick? Why Incyte (INCY) is a Great Choice - sharewise.com

Oct 20, 2025
pulisher
Oct 20, 2025

Multi asset correlation models including Incyte Corporation2025 Price Targets & Precise Trade Entry Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Incyte to Report Third Quarter 2025 Financial Results on October 28 - MyChesCo

Oct 20, 2025
pulisher
Oct 20, 2025

Lobbying Update: $80,000 of INCYTE CORPORATION lobbying was just disclosed - Quiver Quantitative

Oct 20, 2025
pulisher
Oct 19, 2025

Incyte (INCY) Reports Encouraging Clinical Trial Data at ESMO Co - GuruFocus

Oct 19, 2025
pulisher
Oct 19, 2025

Incyte at ESMO Congress 2025: Strategic Focus on Tumor Programs - Investing.com

Oct 19, 2025
pulisher
Oct 19, 2025

Incyte’s cancer drug candidates show promising results in trials - Investing.com

Oct 19, 2025
pulisher
Oct 19, 2025

Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and KRAS G12D Inhibitor in Advanced Pancreatic Ductal Adenocarcinoma - The AI Journal

Oct 19, 2025
pulisher
Oct 18, 2025

What technical charts say about Incyte Corporation stockLong Setup & Long-Term Safe Investment Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Incyte Corporation stock a defensive play in 20252025 Big Picture & Reliable Entry Point Trade Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Bollinger, Credo, Ambarella, Cipher, Incyte: Insider Moves Unveiled! - TipRanks

Oct 18, 2025
pulisher
Oct 17, 2025

Is Incyte Corporation (ICY) stock a defensive play amid uncertaintyWeekly Trend Summary & Real-Time Volume Trigger Notifications - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

How Incyte Corporation stock performs in rising dollar environmentMarket Performance Summary & Proven Capital Preservation Tips - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

InvestingPro’s Fair Value model captures 63% gain in Incyte shares By Investing.com - Investing.com

Oct 17, 2025
pulisher
Oct 17, 2025

Will Incyte Corporation (ICY) stock see insider accumulationMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - newser.com

Oct 17, 2025
pulisher
Oct 16, 2025

How Incyte Corporation stock responds to policy changesTrade Volume Report & Consistent Return Strategy Ideas - newser.com

Oct 16, 2025
pulisher
Oct 16, 2025

Incyte (INCY) Stock Is Up, What You Need To Know - Barchart.com

Oct 16, 2025
pulisher
Oct 16, 2025

Incyte Corporation stock hits 52-week high at 88.78 USD - Investing.com

Oct 16, 2025
pulisher
Oct 15, 2025

Incyte (INCY) Price Target Lifted on CALR Antibody Program Optimism - MSN

Oct 15, 2025
pulisher
Oct 15, 2025

Can Incyte Corporation rally from current levels2025 Top Gainers & Reliable Price Breakout Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Sjogren’s Syndrome Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Gilead Sciences, Incyte Corp, Novartis, GlaxoSmithKline, Janssen Research & Development, LLC - Barchart.com

Oct 15, 2025
pulisher
Oct 15, 2025

Sjogren's Syndrome Market Insights Highlight Expanding - openPR.com

Oct 15, 2025
pulisher
Oct 15, 2025

Incyte Canada Announces Health Canada approval of Opzelura® (Ruxolitinib) Cream for the Treatment of Atopic Dermatitis in Children Ages 2-11 - Yahoo

Oct 15, 2025
pulisher
Oct 15, 2025

Using Python tools to backtest Incyte Corporation strategiesMarket Movers & Fast Entry Momentum Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Incyte's (INCY) EVP and General Counsel Sold 4,100 Shares for $352,000 - The Globe and Mail

Oct 14, 2025
pulisher
Oct 14, 2025

Incyte stock price target raised to $76 from $68 at UBS on valuation By Investing.com - Investing.com South Africa

Oct 14, 2025
pulisher
Oct 14, 2025

Incyte stock price target raised to $76 from $68 at UBS on valuation - Investing.com India

Oct 14, 2025
pulisher
Oct 14, 2025

How ESMO Congress Spotlight on Early Cancer Drugs Could Influence Incyte’s (INCY) Investment Outlook - Yahoo Finance

Oct 14, 2025
pulisher
Oct 13, 2025

Incyte Corp. stock rises Monday, still underperforms market - MarketWatch

Oct 13, 2025
pulisher
Oct 13, 2025

Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the European Society of Medical Oncology (ESMO) Congress 2025 - BioSpace

Oct 13, 2025
$37.30
price down icon 0.47%
$29.85
price down icon 0.96%
$105.65
price down icon 1.22%
$160.38
price down icon 3.03%
biotechnology ONC
$311.87
price down icon 1.03%
Kapitalisierung:     |  Volumen (24h):